Quick Answer
BIOGEN INC. reported Diluted EPS of $8.79 per share for fiscal year 2025.
BIOGEN INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $8.79 | -21.4% |
| 2024 | $11.18 | +40.3% |
| 2023 | $7.97 | -61.8% |
| 2022 | $20.87 | +100.7% |
| 2021 | $10.40 | -58.1% |
| 2020 | $24.80 | -21.1% |
| 2019 | $31.42 | +45.6% |
| 2018 | $21.58 | +81.0% |
| 2017 | $11.92 | -29.6% |
| 2016 | $16.93 | +10.4% |
| 2015 | $15.34 | +24.0% |
| 2014 | $12.37 | +58.4% |
| 2013 | $7.81 | +35.6% |
| 2012 | $5.76 | +14.3% |
| 2011 | $5.04 | +27.9% |
| 2010 | $3.94 | +17.6% |
| 2009 | $3.35 | +26.4% |
| 2008 | $2.65 | +33.2% |
| 2007 | $1.99 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.17 | +19.2% | -26.8% |
| June 30, 2025 | $4.33 | +8.3% | +164.0% |
| March 31, 2025 | $1.64 | -39.3% | -38.3% |
| September 30, 2024 | $2.66 | +666.0% | -33.5% |
| June 30, 2024 | $4.00 | -1.7% | +48.1% |
| March 31, 2024 | $2.70 | +1.1% | +674.5% |
| September 30, 2023 | -$0.47 | -106.0% | -111.5% |
| June 30, 2023 | $4.07 | -43.8% | +52.4% |
- BIOGEN INC. showed a decrease of -21.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, BIOGEN INC.’s diluted eps has grown by 341.7% (from $1.99 per share to $8.79 per share).
- The most recent figure is from BIOGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: